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Abstract
Context: Early identification of Bipolar Disorder (BD) remains poor despite the high levels of disability associated with the
disorder.
Objective: We developed and evaluated a new DSM orientated scale for the identification of young people at risk for BD
based on the Child Behavior Checklist (CBCL) and compared its performance against the CBCL-Pediatric Bipolar Disorder
(CBCL-PBD) and the CBCL-Externalizing Scale, the two most widely used scales.
Methods: The new scale, CBCL-Mania Scale (CBCL-MS), comprises 19 CBCL items that directly correspond to operational
criteria for mania. We tested the reliability, longitudinal stability and diagnostic accuracy of the CBCL-MS on data from the
TRacking Adolescents’ Individual Lives Survey (TRAILS), a prospective epidemiological cohort study of 2230 Dutch youths
assessed with the CBCL at ages 11, 13 and 16. At age 19 lifetime psychiatric diagnoses were ascertained with the Composite
International Diagnostic Interview. We compared the predictive ability of the CBCL-MS against the CBCL-Externalising Scale
and the CBCL-PBD in the TRAILS sample.
Results: The CBCL-MS had high internal consistency and satisfactory accuracy (area under the curve = 0.64) in this general
population sample. Principal Component Analyses, followed by parallel analyses and confirmatory factor analyses, identified
four factors corresponding to distractibility/disinhibition, psychosis, increased libido and disrupted sleep. This factor
structure remained stable across all assessment ages. Logistic regression analyses showed that the CBCL-MS had
significantly higher predictive ability than both the other scales.
Conclusions: Our data demonstrate that the CBCL-MS is a promising screening instrument for BD. The factor structure of
the CBCL-MS showed remarkable temporal stability between late childhood and early adulthood suggesting that it maps on
to meaningful developmental dimensions of liability to BD.
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Introduction
Bipolar Disorder (BD) is a complex mental disorder affecting
between 0.1% and 4.4% of the general population [1]. BD is the
sixth leading cause of disability worldwide particularly amongst
adolescents and young adults [2]. This is partly due to the typically
early onset of BD with the majority of patients presenting between
19–25 years of age [1,3]. More important however is the failure in
recognizing and treating BD particularly in the early stages of the
disorder. The typical delay between onset and diagnosis is 5–10
years [4–6] and is associated with greater clinical severity,
increased psychosocial morbidity and higher treatment costs [7–
9]. Although mania is the diagnostic hallmark of BD [10,11] the
differential diagnosis from Major Depressive Disorder (MDD) is
often difficult as BD is commonly dominated by depressive
symptoms [12,13]. Furthermore, BD is also associated with high
rates (between 60–80%) of psychotic symptoms during mood
episodes [14,15]. High rates of psychotic symptoms have also been
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reported in young patients and confirm their role as a key
symptom dimension of BD in adolescence [16,17]. Additional
diagnostic challenges arise from the symptomatic overlap between
BD and Attention Deficit Hyperactivity Disorder (ADHD), which
also presents with poor attentional and emotional regulation [18].
In response to the need for the early identification of individuals
at high risk for BD there have been several attempts to develop
and validate screening instruments. In adults, one of the most
widely studied screening instruments is the Mood Disorder
Questionnaire (MDQ) [19], a self-report questionnaire based on
the Diagnostic and Statistical Manual of Mental Disorders (DSM)
criteria for mania. A positive MDQ screen is based on participants
endorsing 7 or more lifetime manic symptoms, several co-
occurring, resulting to moderate or serious functional impairment.
In outpatient psychiatric settings the MDQ was reported to
achieve sensitivity and specificity rates of 67%–83% and 86%,
respectively [5]. Although specificity and sensitivity are theoreti-
cally independent of prevalence, in practice they are influenced by
the clinical composition of the sample (e.g. proportion of severe to
mild cases) and interviewers’ assumptions about the frequency of a
disorder [20]. Typically, in general population samples sensitivity
is lower and specificity is higher than that reported in clinical
populations. For example, the sensitivity and specificity of the
MDQ in the general population are respectively 23–25% and 97–
99% [21,22]. Additionally, many individuals with MDD, anxiety
disorders or ADHD screen positive on the MDQ [22,23].
A significant number of screening instruments for juvenile BD
have been developed and have been used mostly in clinical
populations. These include the Parent version of the Young Mania
Rating Scale (P-YMRS) [24], the Parent General Behavior
Inventory (P-GBI) [25], the Adolescent General Behavior Inven-
tory (A-GBI) [26], the Youth Self Report (YSR) [27], the Teacher
Report Form (TRF) [28], the Child Mania Rating Scale (CMRS)
[29], the Child Behaviour Checklist (CBCL) [30], and the Mood
Disorder Questionnaire Adolescent Version (MDQ-A) [31]. The
CBCL [30] is the instrument most commonly used to generate
profiles relevant to BD in youth. The CBCL is a parent report
checklist of 118 items mapping onto multiple aspects of
psychopathology over a 6-month period [30,32]. The CBCL
items are grouped in eight behavioural domains: aggressive
behaviour, anxiety/depression, attention problems, rule-breaking
behavior, withdrawal/depression, somatic complaints, social
problems and thought problems [30]. Different scales have been
generated based on varied combinations of these behavioural
domains. Of relevance to BD, are the Externalizing Scale
(comprising item scores from the rule-breaking and aggressive
behavior domains) and the CBCL-Pediatric Bipolar Disorder scale
(CBCL-PBD) (comprising item scores from the aggressive behav-
ior, anxiety/depression and attention problems domains) [33].
The CBCL-PBD is also referred to as the Dysregulation Profile as
it has been associated with disorder involving extensive behav-
ioural and emotional dysregulation [34] including BD [35].
However all available instruments have limited specificity for BD
as they have been associated with MDD, ADHD and anxiety
disorders [36–40].
Therefore there is still a need for screening instruments for BD
particularly for use in non-clinical populations of young individ-
uals. In an attempt to address this need we developed and
evaluated a new screening scale for BD in children and adolescents
based on the CBCL 6–18 [30]. Despite the limited success of
previous CBCL-based screening instruments for juvenile BD we
decided to use it as the base of the new scale because of its cross-
cultural generalizability [41]. However, instead of using summary
scores of the existing behavioural domains we constructed this new
scale following the methodology defined for DSM-oriented
subscale development by Achenbach et al. (2003) [42]. Content
validity of the new scale was evaluated by an expert panel of child
and adolescent psychiatrists who selected 19 CBCL items that
relate directly to the diagnostic criteria for mania as currently
operationalized in the DSM5 (details in File S1). The new scale
called CBCL-Mania Scale (CBCL-MS) was tested for its
psychometric properties, sensitivity and specificity on data from
the TRacking Adolescents’ Individual Lives Survey (TRAILS)
[http://www.trails.nl/en/] [43]. TRAILS is a prospective study of
an epidemiologically representative cohort of 2230 Dutch
adolescents who were assessed with the full CBCL at age 11,13
and 16. Clinical outcomes were evaluated at age 19 using the
Composite International Diagnostic Interview (CIDI) [44]. We
also compared the performance of the CBCL-MS against the
CBCL-Externalising Scale and the CBCL-PBD to test whether it




The sample consisted of participants of 2230 Dutch youth
participating in the TRacking Adolescents’ Individual Lives
Survey (TRAILS). The sampling procedure and cohort details
for TRAILS have been previously described in detail [43] and can
be found at the study website [http://www.trails.nl/en/]. Briefly,
the cohort includes children born between 1 October 1989 and 30
September 1991 in a well-defined geographic area in the north
Netherlands (information about the representativeness of the
sample in S2). Permission to use anonymised data from the
TRAILS was granted by the study management committee and
ethical approval was granted by the Dutch Central Committee on
Research Involving Human Subjects (CCMO). All data were
anonymised by a research company TNS NIPO [http://www.tns-
nipo.com/].
Assessments
When TRAILS cohort members were 11, 13 and 16 years old,
their parents or parent surrogates completed the CBCL 6–18.
Each CBCL item was scored on a three point scale (0 = not true,
1 = somewhat or sometimes true, 2 = very true or often true) on the
basis of the preceding 6 months. At age 19 years the diagnostic
status of the TRAILS participants was ascertained using the
Computer Assisted Personal Interview version 20 (CAPI) of the
CIDI [http://www.hcp.med.harvard.edu/wmhcidi/]. The CIDI
is a comprehensive, structured interview which was used by
trained lay interviewers to assess mental disorders according to
current diagnostic systems. It has high test-retest reliability for the
diagnosis of BD type I (BD-I) [45] as well as excellent concordance
rates with the Structured Clinical Interview for DSM-IV (SCID)
for lifetime bipolar spectrum disorders [46]. Diagnostic assess-
ments were conducted blind to participants’ CBCL scores.
Child Behavior Check List - Mania Scale (CBCL-MS)
An expert panel of child and adult psychiatrists, based at the
Institute of Psychiatry and the South London and Maudsley NHS
Foundation Trust, independently screened all CBCL items to
select those that correspond to the DSM operational criteria for
mania. As the diagnostic criteria for mania in DSM5 and ICD-10
are identical [www.who.int/classificatios/icd/en/GRNBOOK.
pdf] this selection is applicable to both diagnostic systems. In
addition, the panel considered CBCL items relating to psychotic-
like experiences as childhood and adolescent psychosis and high
Development of the CBCL-MS
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CBCL total scores are frequently associated with later develop-
ment of mania [37–40]. Following consensus meetings, 19 items
were selected for inclusion in the new CBCL- Mania Scale
(CBCL-MS) (Table 1). Detailed information on the item selection
procedure is included in File S1. The scoring of the CBCL-MS at
each assessment age was based on summing the scores of each of
the 19 individual items. Scores were then standardized (T scores)
following the scoring procedure recommended by Achenbach and
Rescorla (2001) [32] using the TRAILS data as the standardiza-
tion sample. Standardization of the CBCL scores for the CBCL-
MS, as well as for other CBCL-based syndrome scales, was
performed separately at each assessment age. The CBCL-MS and
its scoring are available in File S5.
Statistical Analysis
Analyses were performed using IBM SPSS Statistics, Version 19
(www.spss.com) and MPlus 6.0 (www.statmodel.com).
Reliability and validity of the CBCL-MS. As the CBCL-
MS is a new scale the consistency of its items at each assessment
wave was evaluated using Cronbach’s alpha. In order to determine
the number of factors that best describe the latent factor structure
of the CBCL-MS at ages 11, 13 and 16 the following criteria were
considered: the shape of the scree plot, parallel analysis using a
permutated data approach (number of data sets: 5000; confidence
interval 95%) [47,48], the Kaiser criterion as an upper bound for
the number of factors to be retained, and the interpretability of the
obtained factor structure. In order to conduct the parallel analysis,
principal components analysis (PCA) was performed first, with
oblique or varimax rotation (as appropriate). For each assessment
age, the model fit of the final solutions was established using
Confirmatory Factor Analysis (CFA) and assessed using two fit
indices, the Root Mean Square Error of Approximation (RMSEA)
(cut-off values less than 0.06 indicate good fit and values as high as
0.08 represent reasonable errors of approximation in the
population) and the Confirmatory Fit index (CFI) (values above
0.90–0.95 indicate good fit) [49].
Sensitivity and Specificity of the CBCL-MS. Omnibus
tests using the standardized T scores of the CBCL-MS, the CBCL-
Externalizing Scale and the CBCL-PBD were performed to
compare the scores of participants with CIDI diagnoses of BD type
I (BD-I) to those of healthy participants and participants with other
CIDI diagnoses that are considered relevant to BD as they involve
mood abnormalities (anxiety or depression) or inattention and
behavioral disruption. We present data on Major Depressive
Disorder (MDD), General Anxiety Disorder (GAD), and ADHD
as the most pertinent exemplars. Finally, Receiver Operating
Characteristics (ROC) curves [50] were used to calculate the
diagnostic efficiency of the CBCL-MS, CBCL-PBD and CBCL-
Externalizing Scale. A ROC curve illustrates the sensitivity (true
positive rate) of different cut-offs on the y axis and the 1-specificity
(false positive rate) of the corresponding cut-offs on the x axis. In
the ROC analysis, the area under the curve (AUC) statistic
provides a summary of test performance. AUC values range from
0 to 1 with higher values denoting greater discriminative power
and diagnostic efficiency. The focus of the analysis was on BD-I as
the usefulness of a test with poor discriminative ability for core
Table 1. Child Behavior Checklist-Mania Scale items and corresponding core and extended DSM-IV criteria for Mania.
CBCL Items DSM-IV criteria for Mania
Core Symptoms
37. Gets in many fights A distinct period of abnormally and persistently elevated, expansive or irritable mood
87. Sudden changes in mood or feelings
96. Thinks about sex too much
74. Showing off or clowning Inflated self-esteem or grandiosity
94. Teases a lot
76. Sleeps less than most kids Decreased need for sleep (e.g., feels rested after only 3 hours of sleep)
100. Trouble sleeping
93. Talks too much More talkative than usual or pressure to keep talking
104. Unusually loud Flight of ideas or subjective experience that thoughts are racing
78. Inattentive or easily distracted Distractibility (i.e., attention too easily drawn to unimportant or irrelevant external
stimuli)
10. Can’t sit still, restless or hyperactive Increase in goal-directed activity (at work, at school, or sexually) or psychomotor
agitation
60. Plays with own sex parts too much
41. Impulsive or acts without thinking Excessive involvement in pleasurable activities that have a high potential for painful
consequences (e.g., engaging in unrestrained buying sprees, sexual indiscretions, or
foolish business investments)
59. Plays with own sex parts in public
Extended Symptoms
34. Feels others are out to get him/her Delusions
85. Strange ideas
89.Suspicious
40. Hears sound or voices that aren’t there Hallucinations
70. Sees things that aren’t there
doi:10.1371/journal.pone.0069459.t001
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syndromal BD would be questionable. However, we also
performed ROC analysis using a more expanded definition of
caseness that also included BD type II (BD-II) and hypomania
with no major depressive episode.
Results
TRAILS participants with BD
At age 19, 56 of the TRAILS participants were diagnosed with
BD-I. Thirty-four cases had attracted other psychiatric diagnoses
prior to being diagnosed with BD; seventeen had a single previous
diagnosis either for Oppositional Defiant Disorder (ODD) (n= 5)
or Conduct Disorder (CD) (n = 5) or ADHD (n= 4) or GAD
(n=3). Of the remaining seventeen BD cases, eleven had two prior
diagnoses (ADHD/ODD=2, ADHD/CD=1, ADHD/GAD=1,
ADHD/MDD=1, ODD/CD=3, ODD/GAD=2, ODD/
MDD=1), five had three prior diagnoses (ODD/CD/GAD=3,
ODD/CD/ADHD=2) and one had four (ODD/CD/ADHD/
GAD).
Internal consistency and factor structure of the CBCL-MS
Reliability analysis demonstrated high internal consistency for
the 19 items of the CBCL-MS at all assessment ages (Cronbach’s
alpha$80; total item correlation .0.37). A PCA of the CBCL-MS
data assessed at age 16 extracted four factors corresponding to: (1)
distractibility/disinhibition (2) psychotic symptoms (3) increased
libido (4) disrupted sleep (Figure 1). These factors were plausible
and interpretable as items’ loading segregated among the four
factors as shown in File S3 and Table S2. The factor structure
represents the orthogonal solution of the PCA, as the factors
extracted using oblique rotation were only weakly correlated
(r,0.3). Both the Parallel Analysis and Kaiser’s criterion supported
the retention of four factors. The scree plot of the extracted
eigenvalues from the parallel analysis is given in Figure S1,
available on line. Analyses of the CBCL-MS data at ages 11 and
13 years resulted in an almost identical factor structure indicating
longitudinal stability of this solution (File S3 and Tables S2, S3 and
S4). Confirmatory factor analyses further supported the goodness
of fit of 4-factor structure (RMSEA#0.05 and CFI$0.92).
Discriminative ability and performance of the CBCL-MS
Table 2 presents the mean total and CBCL-MS factor scores for
TRAILS participants who were diagnosed with BD-I and for those
who did not have any lifetime psychiatric diagnosis. Participants
with BD had significantly higher mean total CBCL-MS scores
compared with participants with MDD (n= 178; p = 0.002) and
GAD (N=20; p = 0.004) but not ADHD (N=26; p.0.05)
(Figure 2).
The ROC curve analysis on the CBCL-MS data at age 16 is
illustrated in Figure 3. The AUC was 0.64 (p,0.01) which
represents a satisfactory performance for a general population
sample with low prior probability of true positives. The AUC
remained unchanged when caseness was expanded to include BD-
II and hypomania without major depressive episode. Moreover,
the total CBCL-MS score performed better than the scores of each
individual factors used independently or sequentially (details in
supporting information S4 and Tables S5 and S6).
Comparison to CBCL-PBD: TRAILS participants with BD-I
had significantly higher CBCL-PBD mean scores (56.51,
SD=15.91) in comparison to healthy participants (49.79,
SD=9.69) but not compared to participants with MDD
(p= 0.54), GAD (p= 0.51) or ADHD (p= 0.37). ROC curve
analysis showed a moderate ability of the CBCL-PBD in
distinguishing BD-I cases from healthy TRAILS participants
(AUC=61%, p= 0.002).
Comparison to the Externalizing scale of the CBCL: External-
izing scale mean scores were significantly higher for TRAILS
participants with BD-I (58.49, SD=18.27) in comparison to
healthy participants (48.44, SD=8.25) and participants with
MDD (52.00, SD=9.80) or GAD (50.52, SD=7.80), but not
compared to participants with ADHD (p= 0.23). ROC analysis
showed that the Externalizing scale had AUC=63%, p= 0.003
when discriminating between TRAILS cases with BD-I and
healthy participants.
A forward stepwise logistic regression model showed that the
CBCL-MS had significantly increased ability to predict BD-I
compared to the CBCL-PBD (Wald x2 = 12.69, p,0.001) and the
CBCL-Externalizing Scale (Wald x2 = 3.47, p = 0.05).
Discussion
We present data on the psychometric properties and discrim-
inative ability of the CBCL-MS, a new DSM based screening scale
for BD-I based on the CBCL. We demonstrate that the new scale
has excellent psychometric properties; its discriminative ability and
accuracy in a general population sample of young people represent
an improvement over other commonly used scales particularly
CBCL-PBD and the CBCL-Externalizing Scale.
Prevalence and Characteristics of TRAILS participants
with BD
The lifetime prevalence of BD-I in the TRAILS sample was
2.5% which is identical to that reported in a recent epidemiolog-
ical study of US adolescents [51]. Also consistent with previous
literature, nearly 61% of BD-I cases in the TRAILS sample had
prior diagnoses associated with disruptive behaviour most
commonly ADHD and ODD [18,50–54].
Factor Structure of the CBCL-MS reveals developmentally
meaningful dimensions of liability to BD
The structural model of the CBCL-MS consisted of four factors.
These factors correspond to dimensions of distractibility/disinhi-
bition, psychosis, increased libido and disrupted sleep. The factor
structure of the CBCL-MS showed remarkable temporal stability
between the ages of 11 to 16 which strongly supports the notion
that it defines developmentally meaningful dimensions of liability
to BD. This report is the first to describe developmental
dimensions of liability to BD. All other studies have focused on
symptom dimensions during acute manic episodes in patients with
established BD [54–58]. Nevertheless, there are significant
similarities. Cassidy and colleagues identified 5 factors in acute
mania of which the ‘‘psychomotor pressure’’, ‘‘psychosis’’ and
‘‘increased hedonic’’ factors correspond to the distractibility/
disinhibition, psychosis and increased libido factors in this study
[55]. Picardi et al [56] defined a four factor structure of acute
mania based on the Brief Psychiatric Rating Scale. The factors
they named ‘‘mania’’ and ‘‘disorganisation’’ include items similar
to the distractibility/disinhibition factor identified here. In
addition their ‘‘positive symptoms’’ factor overlaps with the
psychosis factor in this study. Cassano et al [57] identified 5
factors in acute mania of which ‘‘psychomotor agitation’’ and
‘‘psychoticism’’ correspond to the factors of distractibility/disinhi-
bition and psychosis in the TRAILS cohort. All three studies also
defined factors relating to dysphoric/euphoric mood and aggres-
sion that seem to be present only during acute mania and may not
represent an independent dimension of developmental liability to
BD.
Development of the CBCL-MS
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Discriminative ability of the CBCL-MS
The overall accuracy was 0.64 for the CBCL-MS and CBCL-
Externalising Scale and 0.61 for the CBCL-PBD. The results of
the logistic regression comparing the three scales showed that the
CBCL-MS was statistically better in predicting BD outcome.
As seen by the ROC, different cut-off scores will influence the
sensitivity and specificity of the CBCL-MS. In general population
screening the emphasis is usually on specificity thus selecting
individuals at highest risk for detailed follow-up assessments. To
illustrate this point, in a hypothetical community sample of 10000
youth with a 2.5% prevalence of BD we would expect 250
individuals to have BD (true positives). A CBCL-MS score of 70 or
above will correctly identify 8,775 individuals (90% of this sample)
as not having BD (true negatives). At the same threshold, 1,050
individuals will be classified as possible cases. This sample will
include 75 true cases of BD (true positives) and 975 individuals
without BD (false positives). At first glance, one might be
concerned about the number of false positive cases. However,
those scoring above 70 in the CBCL-MS were at a six-fold
increased risk for BD (Positive Predictive Value: 16.57%; Negative
Predictive Value: 98.01%) compared to the rest of the sample and
therefore they represent a high risk group. The field of early
Figure 1. Factors and Factor Loadings of the Child Behavior Checklist-Mania Scale.
doi:10.1371/journal.pone.0069459.g001
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intervention in BD is currently in its infancy [59] but as effective
therapies become available [60] scales such as the CBCL-MS may
contribute to the identification of those at high risk.
None of the scales differentiated participants with BD from
those with ADHD in terms of mean scores. The relationship
between these two disorders is complex. Available evidence
suggests at least partially overlapping aetiology and pathophysiol-
ogy for BD and ADHD because of familial co-segregation of the
two disorders [61,62], commonalities in their neurobiological
correlates [18,63,64], and frequent comorbidity [18]. Additionally,
there is significant overlap in the symptoms of the two disorders
particularly with regards to increased activity, talkativeness and
mood dysregulation [10,11]. Two main features distinguishing BD
from ADHD have been proposed. Geller and colleagues
emphasized the importance of either elevated mood or grandiosity
for a diagnosis of mania [65]. However, in our study these
symptoms clustered with others in one factor and did not differ
across the two diagnostic categories. Others have suggested that
Figure 2. Child Behavior Checklist-Mania Scale Scores in TRAILS Participants.
doi:10.1371/journal.pone.0069459.g002
Table 2. Child Behavior Checklist-Mania Scale total and Factor Scores in TRAILS participants with Bipolar Disorder (BD) and healthy
participants.
BD participants (N=56) Healthy Participants (N=1201)
Mean Score (Standard Deviation) p
Total CBCL-MS 57.28 (16.08) 49.33 (8.95) ,0.001
Distractibility/Disinhibition 56.01 (14.71) 49.18 (8.98) ,0.001
Psychotic Symptoms 56.19 (20.20) 49.44 (8.84) ,0.001
Increased Libido 51.99 (12.28) 49.48 (8.88) 0.088
Disrupted Sleep 54.42 (12.28) 49.63 (9.33) 0.002
doi:10.1371/journal.pone.0069459.t002
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episodicity is more indicative of BD than ADHD [66] but this
distinction seems less clear in children and adolescents [51]. It is
therefore possible that scales based on observed behaviour lack
assay sensitivity in distinguishing between BD and ADHD.
Methodological Issues and Future Directions
The present study has a number of strengths and limitations.
The TRAILS sample is representative of the population of young
people in the Netherlands (Table S6). The prevalence of BD in the
TRAILS is nearly identical to that of general population samples
elsewhere [1,51] which supports the generalizability of findings.
Case ascertainment in the TRAILS does not depend on help-
seeking behaviour or concern about impairment or severity and
thus the sample is free from referral bias present in clinical
populations. However, the CIDI although widely used is designed
for lay interviewers who rely on its structured format and may not
probe or interpret participant responses further. Case ascertain-
ment was conducted at age 19. Since participants have not yet
passed the entire period of risk for BD it is possible that further
cases of BD may present in the future.
The CBCL-MS performed well within the context of a general
population sample, it represents an improvement on available
scales and could contribute to future public health initiatives for
the identification of youth at high risk for BD. Its accuracy is
moderate and in the same broad range of the other CBCL-based
screening instruments. Although it could be argued that this is
reflects limitations in the CBCL we would suggest that behavioural
ratings alone are unlikely to provide us with high levels of accuracy
in case identification for BD or any mental disorder. However a
great strength of this study was the availability of CBCL
assessments at multiple time points from late childhood to early
adulthood. This allowed us to test the temporal stability of the
CBCL-MS factors which supports the validity of these dimensions
as developmentally meaningful premorbid indicators of BD.
Supporting Information
Figure S1 Scree Plot.
(TIF)
File S1 Selection of Items for the CBCL-MS.
(DOC)
File S2 Representativeness of the TRAILS sample.
(DOC)
File S3 Psychometric properties of the CBCL-MS across
ages.
(DOC)
File S4 Discriminative ability of the CBCL-MS.
(DOC)
File S5 Appendix: CBCL-MS (scale and scoring sheet).
(PDF)
Acknowledgments
Participating centers of TRAILS in the Netherlands, including the
University Medical Center and University of Groningen, the Erasmus
University Medical Center Rotterdam, the University of Utrecht, the
Radboud Medical Center Nijmegen, and the Parnassia Bavo group.
Author Contributions
Conceived and designed the experiments: JO AO SF AR. Conceived and
designed the experiments: JO AO SF AR. Performed the experiments: JO
AO. Performed the experiments: JO AO. Analyzed the data: EP SF AR.
Analyzed the data: EP SF AR. Contributed reagents/materials/analysis
tools: EP SF AR MR MK. Contributed reagents/materials/analysis tools:
EP SF AR MR MK. Wrote the paper: EP JO AO MKMR AR SF. Wrote
the paper: EP JO AO MK MR AR SF.
Figure 3. Receiver Operating Characteristics curve of the Child Behavior Checklist-Mania Scale for Bipolar Disorder vs. healthy
TRAILS participants.
doi:10.1371/journal.pone.0069459.g003
Development of the CBCL-MS
PLOS ONE | www.plosone.org 7 August 2013 | Volume 8 | Issue 8 | e69459
References
1. Merikangas KR, Jin R, He JP, Kessler RC, Lee S, et al (2011) Prevalence and
correlates of bipolar spectrum disorder in the world mental health survey
initiative. Arch Gen Psychiatry 68: 241–251.
2. Murray CJ, Lopez AD, Jamison DT (1994) The global burden of disease in
1990: summary results, sensitivity analysis and future directions. Bull World
Health Organ 72: 495–509.
3. Perlis RH, Miyahara S, Marangell LB, Wisniwski SR, Ostacher M (2004) Long-
term implications of early onset in bipolar disorder: data from the first 1000
participants in the systematic treatment enhancement program for bipolar
disorder (STEP-BD). Biol Psychiatry 55: 875–881.
4. Lish JD, Dime-Meenan S, Whybrow PC, Price RA, Hirschfeld RM (1994) The
National Depressive and Manic-depressive Association (DMDA) survey of
bipolar members. J Affect Disord 31: 281–294.
5. Hirschfeld RM, Lewis L, Vornik LA (2003) Perceptions and impact of bipolar
disorder: how far have we really come? Results of the national depressive and
manic-depressive association 2000 survey of individuals with bipolar disorder.
J Clin Psychiatry 64: 161–174.
6. Berk M, Dodd S, Callaly P, Berk L, Fitzgerald P, et al. (2007) History of illness
prior to a diagnosis of bipolar disorder or schizoaffective disorder. J Affect
Disord 103: 181–186.
7. Keck PE Jr, Kessler RC, Ross R (2008) Clinical and economic effects of
unrecognized or inadequately treated bipolar disorder. J Psychiatr Pract 14
Suppl 2: 31–38.
8. Post RM, Leverich GS, Kupka RW, Keck PE Jr, McElroy SL, et al (2010) Early-
onset bipolar disorder and treatment delay are risk factors for poor outcome in
adulthood. J Clin Psychiatry 71: 864–872.
9. Ketter TA (2011) Strategies for the early recognition of bipolar disorder. J Clin
Psychiatry 72: e22.
10. American Psychiatric Association (2013) Diagnostic and Statistical Manual for
Mental Disorders, 5th Edition (DSM5). Washington, D.C.: American Psychiatric
Association.
11. World Health Organisation (1992) ICD-10 Classifications of Mental and
Behavioural Disorder: Clinical Descriptions and Diagnostic Guidelines. Geneva:
World Health Organisation.
12. Perugi G, Micheli C, Akiskal HS, Madaro D, Socci C, et al (2000) Polarity of the
first episode, clinical characteristics, and course of manic depressive illness: a
systematic retrospective investigation of 320 bipolar I patients. Compr
Psychiatry 41: 13–18.
13. Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, et al (2002) The long-
term natural history of the weekly symptomatic status of bipolar I disorder. Arch
Gen Psychiatry 59: 530–537.
14. Keck PE Jr, McElroy SL, Havens JR, Altshuler LL, Nolen WA (2003) Psychosis
in bipolar disorder: Phenomenology and impact on morbidity and course of
illness. Compr Psychiatry 44: 263–269.
15. Coryell W, Leon AC, Turvey C, Akiskal HS, Mueller T, et al (2001) The
significance of psychotic features in manic episodes: A report from the NIMH
collaborative study. J Affect Disord 67: 79–88.
16. Johns LC, Nazroo JY, Bebbington P, Kuipers E (2002) Occurrence of
hallucinatory experiences in a community sample and ethnic variations.
Br J Psychiatry 180:174–178.
17. Topor DR, Swenson L, Hunt JI, Birmaher B, Strober M, et al (2013) Manic
symptoms in youth with bipolar disorder: Factor analysis by age of symptom
onset and current age. J Affect Disord 145: 409–412.
18. Skirrow C, Hosang GM, Farmer AE, Asherson P (2012) An update on the
debated association between ADHD and bipolar disorder across the lifespan.
J Affect Disord 141:143–159.
19. Hirschfeld RM, Williams JB, Spitzer RL, Calabrese JR, Flynn L (2000)
Development and validation of a screening instrument for bipolar spectrum
disorder: the Mood Disorder Questionnaire. Am J Psychiatry 157: 1873–1875.
20. Robins LN (1985) Epidemiology: reflections on testing the validity of psychiatric
interviews. Arch Gen Psychiatry 42: 918–924.
21. Hirschfeld RM, Holzer C, Calabrese JR, Weissman M, Reed M (2003) Validity
of the mood disorder questionnaire. Am J Psychiatry 160:178–180.
22. Dodd S, Williams LJ, Jacka FN, Pasco JA, Bjerkeset O, et al (2009) Reliability of
the Mood Disorder Questionnaire: comparison with the Structured Clinical
Interview for the DSM-IV-TR in a population sample. Aust N Z J Psychiatry 43:
526–530.
23. Zimmerman M, Galione JN, Ruggero CJ, Chelminski I, Dalrymple K, et al
(2011) Are screening scales for bipolar disorder good enough to be used in
clinical practice? Compr Psychiatry 52:600–606.
24. Gracious BL, Youngstrom EA, Findling RL, Calabrese JR (2002) Discriminative
validity of a parent version of the Young Mania Rating Scale. J Am Acad Child
Adolesc Psychiatry 41:1350–1359.
25. Youngstrom EA, Findling RL, Danielson CK, Calabrese JR (2001) Discrimi-
native validity of parent report of hypomanic and depressive symptoms on the
General Behavior Inventory.Psychol Assess 13:267–276.
26. Danielson CK, Youngstrom EA, Findling RL, Calabrese JR (2003) Discrimi-
native validity of the general behavior inventory using youth report. J Abnorm
Child Psychol 31:29–39.
27. Achenbach TM (1991) Integrative guide for the 1991 CBCL/4-18, YSR and
TRF profiles. Deaprtment of Psychiatry, Burlington, VT: University of Vermont
28. Achenbach TM (1991) Manual for the Teacher Report Form and 1991 profile.
Deaprtment of Psychiatry, Burlington, VT: University of Vermont.
29. Pavuluri MN, Henry DB, Devineni B, Carbray JA, Birmaher B (2006) Child
mania rating scale: development, reliability, and validity. J Am Acad Child
Adolesc Psychiatry 45:550–560.
30. Achenbach TM (1991) Manual for the Child Behavior Checklist/4-18 and 1991
Profile. Department of Psychiatry. Burlington, VT: University of Vermont.
31. Wagner KD, Hirschfeld RM, Emslie GJ, Findling RL, Gracious BL, et al (2006)
Validation of the Mood Disorder Questionnaire for bipolar disorders in
adolescents. J Clin Psychiatry 67:827–830.
32. Achenbach TM, Rescorla LA (2001) Manual for the ASEBA School-Age Forms
& Profiles. Research Center for Children, Youth and Families. Burlington, VT:
University of Vermont.
33. Biederman J, Wozniak J, Kiely K, Ablon S, Faraone S, et al (1995) CBCL
clinical scales discriminate prepubertal children with structured interview-
derived diagnosis of mania from those with ADHD. J Am Acad Child Adolesc
Psychiatry 34: 464–471.
34. Kim J, Carlson GA, Meyer SE, Bufferd SJ, Dougherty LR, et al (2012)
Correlates of the CBCL-dysregulation profile in preschool-aged children. J Child
Psychol Psychiatry 53: 918–926.
35. Faraone SV, Althoff RR, Hudziak JJ, Monuteaux M, Biederman J (2005) The
CBCL predicts DSM bipolar disorder in children: a receiver operating
characteristic curve analysis. Bipolar Disord 7: 518–524.
36. Mick E, Biederman J, Pandina G, Faraone SV (2003) A preliminary meta-
analysis of the child behavior checklist in pediatric bipolar disorder. Biol
Psychiatry 53:1021–1027
37. Youngstrom EA, Findling RL, Calabrese JR, Gracious BL, Demeter C, et al
(2004) Comparing the diagnostic accuracy of six potential screening instruments
for bipolar disorder in youths aged 5 to 17 years. J Am Acad Child Adolesc
Psychiatry 43:847–858.
38. Volk HE, Todd RD (2007) Does the Child Behavior Checklist Juvenile Bipolar
Disorder Phenotype Identify Bipolar Disorder? Biol Psychiatry 62: 115–120.
39. Diler RS, Birmaher B, Axelson D, Goldstein B, Gill M, et al (2009) The Child
Behavior Checklist (CBCL) and the CBCL-bipolar phenotype are not useful in
diagnosing pediatric bipolar disorder. J Child Adolesc Psychopharmacol 19: 23–
30.
40. Althoff RR, Verhulst FC, Rettew DC, Hudziak JJ, van der Ende J (2010) Adult
outcomes of childhood dysregulation: a 14-year follow-up study. J Am Acad
Child Adolesc Psychiatry 49: 1105–1116.
41. Ivanova MY, Dobrean A, Dopfner M, Erol N, Fombonne E, et al (2007) Testing
the 8-syndrome structure of the child behavior checklist in 30 societies. Holland
to Australia. J Clin Child Adolesc Psychol 36: 405–417.
42. Achenbach TM, Dumenci L, Rescorla LA (2003) DSM-oriented and empirically
based approaches to constructing scales from the same item pools. J Clin Child
Adolesc Psychol 32: 328–340.
43. Huisman M, Oldehinkel AJ, de Winter A, Minderaa RB, de Bildt A, et al (2008)
Cohort Profile: The Dutch ‘TRacking Adolescents’ Individual Lives ‘Survey’;
TRAILS. Int J Epidemiol 37: 1227–1235.
44. World Health Organisation (1990) Composite International Diagnostic
Interview (CIDI). Geneva:World Health Organisation.
45. Wittchen HU (1994) Reliability and validity studies of the WHO–Composite
International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res
28:57–84.
46. Kessler RC, Akiskal HS, Angst J, Guyer M, Hirschfeld RM, et al (2006)Validity
of the assessment of bipolar spectrum disorders in the WHO CIDI 3.0. J Affect
Disord 96:259–269.
47. Horn JL (1965) A rationale and test for the number of factors in factor
analysis.Psychometrika 30:179–185.
48. Zwick WR, Velicer WF (1986) Comparison of Five Rules for Determining the
Number of Components to Retain. Psychol Bull 99: 432–442.
49. Hu Lt, Bentler PM (1999) Cutoff criteria for fit indexes in covariance structure
analysis: Conventional criteria versus new alternatives. Struct Equ Modeling 6:
1–55.
50. Grzybowski M, Younger JG (1997) Statistical methodology: III. Receiver
operating characteristic (ROC) curves. Acad Emerg Med 4: 818–826.
51. Merikangas KR, Cui L, Kattan G, Carlson GA, Youngstrom EA, et al (2012)
Mania with and without depression in a community sample of US adolescents.
Arch Gen Psychiatry 69:943–951.
52. Biederman J, Faraone SV, Wozniak J, Mick E, Kwon A, et al (2004) Further
evidence of unique developmental phenotypic correlates of pediatric bipolar
disorder: findings from a large sample of clinically referred preadolescent
children assessed over the last 7 years. J Affect Disord 82 Suppl 1: S45–58.
53. Duffy A, Alda M, Crawford L, Milin R, Grof P (2007) The early manifestations
of bipolar disorder: a longitudinal prospective study of the offspring of bipolar
parents. Bipolar Disord 9:828–838.
54. Biederman J, Petty CR, Monuteaux MC, Mick E, Parcell T, et al (2008) The
longitudinal course of comorbid oppositional defiant disorder in girls with
attention-deficit/hyperactivity disorder: findings from a controlled 5-year
prospective longitudinal follow-up study. J Dev Behav Pediatr 29: 501–507.
55. Cassidy F, Forest K, Murry E, Carroll BJ (1998) A Factor analysis of the signs
and symptoms of mania. Arch Gen Psychiatry 55: 27–32.
Development of the CBCL-MS
PLOS ONE | www.plosone.org 8 August 2013 | Volume 8 | Issue 8 | e69459
56. Picardi A, Battisti F, de Girolamo G, Morosini P, Norcio B, et al (2008)
Symptom structure of acute mania: a factor study of the 24-item Brief
Psychiatric Rating Scale in a national sample of patients hospitalized for a manic
episode. J Affect Disord 108:183–189.
57. Cassano GB, Mula M, Rucci P, Miniati M, Frank E, et al (2009) The structure
of lifetime manic-hypomanic spectrum. J Affect Disord 112: 59–70.
58. Agrawal A, Nurnberger JI Jr, Lynskey MT (2010) Item response modeling of
DSM-IV mania symptoms in two representative US epidemiological samples.
Psychol Med 40:1549–1558.
59. Berk M, Hallam K, Malhi GS, Henry L, Hasty M, et al (2010) Evidence and
implications for early intervention in bipolar disorder. J Ment Health 19:113–
126.
60. Miklowitz DJ, Schneck CD, Singh MK, Taylor DO, George EL, et al (2013)
Early intervention for symptomatic youth at risk for bipolar disorder: a
randomized trial of family-focused therapy. J Am Acad Child Adolesc Psychiatry
52:121–131.
61. Neslihan Inal-Eiroglu F, Ozerdem A, Miklowitz D, Baykara A, Akay A (2008)
Mood and disruptive behavior disorders and symptoms in the offspring of
patients with bipolar I disorder. World Psychiatry 7:110–112.
62. Faraone SV, Biederman J, Mennin D, Wozniak J, Spencer T (1997) Attention-
deficit hyperactivity disorder with bipolar disorder: a familial subtype? J Am
Acad Child Adolesc Psychiatry 36: 1378–1387.
63. Passarotti AM, Sweeney JA, Pavuluri MN (2010) Neural correlates of response
inhibition in pediatric bipolar disorder and attention deficit hyperactivity
disorder. Psychiatry Res 181:36–43.
64. Passarotti AM, Sweeney JA, Pavuluri MN (2010) Emotion processing influences
working memory circuits in pediatric bipolar disorder and attention-deficit/
hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 49:1064–1080.
65. Geller B, Williams M, Zimerman B, Frazier J, Beringer L, et al (1998)
Prepubertal and and early adolescent bipolarity differentiate from ADHD by
manic symptoms, grandiose delusions, ultra-rapid or ultradian cycling. J Affect
Disord 51:81–91.
66. Leibenluft E, Rich BA (2008) Pediatric bipolar disorder. Annu Rev Clin Psychol
4: 163–187.
Development of the CBCL-MS
PLOS ONE | www.plosone.org 9 August 2013 | Volume 8 | Issue 8 | e69459
